南大蘇富特(08045.HK)年度虧損收窄至3945.1萬元
格隆匯3月28日丨南大蘇富特(08045.HK)公佈,截至2019年12月31日止年度,公司實現收入3.87億元,同比減少19.27%;毛利5330.5萬元,同比增長6.37%;公司擁有人應占虧損3945.1萬元,去年同期則為虧損5369.8萬元;基本每股虧損1.20分。
本年度,受電子商務技術市場及本集團對毛利率較低業務持續調整的影響,電腦硬件及軟件的銷售額較去年同期下降約1.597億元。
公司擁有人應占的虧損減少主要由於融資成本減少約241.9萬元所致。此外,由於集團維持對應收款項的嚴格控制,截至2019年12月31日的減值虧損較2018年同期減少約1560.4萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.